Moderna could make experimental COVID-19 vaccine available to healthcare workers by fall
There are some hard limits to the vaccine development process that mean we are not going to see any preventative immune therapies to fight the new coronavirus for at least a year to 18 months. But Moderna, which is behind the first potential vaccine to enter human clinical trials in the U.S., provided new info on Monday that indicates it will seek to provide access to the vaccine by as early as this fall, to a limited group likely consisting of healthcare workers.
The company will look at possibly doing so under an emergency use authorization from eh Food and Drug Administration, which is similar to how certain testing procedures are being granted approval for use now, bypassing the typical process under which such diagnostic tools are given the go-ahead. Moderna’s solution which was developed in partnership with the National Institute of Allergy and Infectious Diseases, is already the fastest potential vaccine to enter the human clinical trial phase.
Their proposed vaccine makes use of messenger RNA, rather than relying on either a small or inactive sample of the COVID-19 virus itself – the source of most existing effective vaccines. The mRNA method means that there is no actual virus introduced to subjects who receive it, which in turn means that they are not at risk of actually contracting the virus form the vaccine itself, which can be an issue in the testing and development phase of any traditional virus-based immune therapy.
Last Monday, Moderna began providing the vaccine to volunteer participants in the first phase of its human clinical trial in Washington state. Despite the speed with which it entered human testing, and the unconventional bypass of the animal testing phase, commercial availability is still at least a year away. But select, limited use for healthcare professionals at an accelerated timetable could help provide additional protection for frontline workers who are risking greater exposure to curtail the pandemic’s spread – provided Moderna’s vaccine is effective, and proves safe in its current human testing.
Moderna’s solution works by convincing the body to generate proteins that resemble the virus but that are harmless, and provoke antibodies that is effective both in fighting off the protein and the actual virus itself. There are other RNA-based vaccines in development, as well as other types of immune treatments, but only Moderna’s has reached the clinical trial phase thus far. The Boston-based company has been working on mRNA-based treatments for cancer cells, and went public in December 2018.
There are some hard limits to the vaccine development process that mean we are not going to see any preventative immune therapies to fight the new coronavirus for at least a year to 18 months. But Moderna, which is behind the first potential vaccine to enter human clinical trials in…
Recent Posts
- Discord’s updated Terms of Service are exactly the wrong response to its recent data breaches
- GE Café Specialty Grind and Brew Coffee Maker Review: Can’t Make Just One Cup
- Microsoft is mulling a change for widgets in Windows 11 that could prove controversial
- What to look for in your first turntable in 2024
- ICYMI: the 8 biggest tech news stories from Boston Dynamic’s new robot to Sony’s OLED-beating Micro-LED TV tech
Archives
- April 2024
- March 2024
- February 2024
- January 2024
- December 2023
- November 2023
- October 2023
- September 2023
- August 2023
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- December 2011